Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.

O'Malley KJ, Bowling JD, Stinson E, Cole KS, Mann BJ, Namjoshi P, Hazlett KRO, Barry EM, Reed DS.

PLoS One. 2018 Oct 22;13(10):e0205928. doi: 10.1371/journal.pone.0205928. eCollection 2018. Erratum in: PLoS One. 2018 Nov 15;13(11):e0207721.

2.

Kinesin-5 Regulation and Function in Mitosis.

Mann BJ, Wadsworth P.

Trends Cell Biol. 2019 Jan;29(1):66-79. doi: 10.1016/j.tcb.2018.08.004. Epub 2018 Sep 13. Review.

PMID:
30220581
3.

Distribution of Eg5 and TPX2 in mitosis: Insight from CRISPR tagged cells.

Mann BJ, Wadsworth P.

Cytoskeleton (Hoboken). 2018 Dec;75(12):508-521. doi: 10.1002/cm.21486. Epub 2018 Nov 15.

PMID:
30123975
4.

Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species.

Moreau GB, Qin A, Mann BJ.

J Bacteriol. 2018 Jan 24;200(4). pii: e00587-17. doi: 10.1128/JB.00587-17. Print 2018 Feb 15.

5.

Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.

Gorla SK, Zhang Y, Rabideau MM, Qin A, Chacko S, House AL, Johnson CR, Mandapati K, Bernstein HM, McKenney ES, Boshoff H, Zhang M, Glomski IJ, Goldberg JB, Cuny GD, Mann BJ, Hedstrom L.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00939-17. doi: 10.1128/AAC.00939-17. Print 2017 Oct.

6.

Src family kinase phosphorylation of the motor domain of the human kinesin-5, Eg5.

Bickel KG, Mann BJ, Waitzman JS, Poor TA, Rice SE, Wadsworth P.

Cytoskeleton (Hoboken). 2017 Sep;74(9):317-330. doi: 10.1002/cm.21380. Epub 2017 Jul 25.

7.

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.

Clin Vaccine Immunol. 2017 Mar 6;24(3). pii: e00574-16. doi: 10.1128/CVI.00574-16. Print 2017 Mar.

8.

Regulation of Kif15 localization and motility by the C-terminus of TPX2 and microtubule dynamics.

Mann BJ, Balchand SK, Wadsworth P.

Mol Biol Cell. 2017 Jan 1;28(1):65-75. doi: 10.1091/mbc.E16-06-0476. Epub 2016 Nov 16.

9.

Using Fluorescence Microscopy to Study Mitosis.

Balchand SK, Mann BJ, Wadsworth P.

Methods Mol Biol. 2016;1413:3-14. doi: 10.1007/978-1-4939-3542-0_1.

10.

Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 1: Biologics Overview, Ligament Injury, Tendinopathy.

LaPrade RF, Geeslin AG, Murray IR, Musahl V, Zlotnicki JP, Petrigliano F, Mann BJ.

Am J Sports Med. 2016 Dec;44(12):3270-3283. Epub 2016 Mar 29.

PMID:
27159318
11.

Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 3: Articular Cartilage.

Zlotnicki JP, Geeslin AG, Murray IR, Petrigliano FA, LaPrade RF, Mann BJ, Musahl V.

Orthop J Sports Med. 2016 Apr 15;4(4):2325967116642433. doi: 10.1177/2325967116642433. eCollection 2016 Apr.

12.

Biologic Treatments for Sports Injuries II Think Tank-Current Concepts, Future Research, and Barriers to Advancement, Part 2: Rotator Cuff.

Murray IR, LaPrade RF, Musahl V, Geeslin AG, Zlotnicki JP, Mann BJ, Petrigliano FA.

Orthop J Sports Med. 2016 Mar 31;4(3):2325967116636586. doi: 10.1177/2325967116636586. eCollection 2016 Mar.

13.

Components of the type six secretion system are substrates of Francisella tularensis Schu S4 DsbA-like FipB protein.

Qin A, Zhang Y, Clark ME, Moore EA, Rabideau MM, Moreau GB, Mann BJ.

Virulence. 2016 Nov 16;7(8):882-894. Epub 2016 Mar 30.

14.

Suppression of microtubule assembly kinetics by the mitotic protein TPX2.

Reid TA, Schuster BM, Mann BJ, Balchand SK, Plooster M, McClellan M, Coombes CE, Wadsworth P, Gardner MK.

J Cell Sci. 2016 Apr 1;129(7):1319-28. doi: 10.1242/jcs.178806. Epub 2016 Feb 11.

15.

Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity.

Schutte KM, Fisher DJ, Burdick MD, Mehrad B, Mathers AJ, Mann BJ, Nakamoto RK, Hughes MA.

Infect Immun. 2015 Nov 9;84(1):320-8. doi: 10.1128/IAI.00552-15. Print 2016 Jan.

16.

TPX2 Inhibits Eg5 by Interactions with Both Motor and Microtubule.

Balchand SK, Mann BJ, Titus J, Ross JL, Wadsworth P.

J Biol Chem. 2015 Jul 10;290(28):17367-79. doi: 10.1074/jbc.M114.612903. Epub 2015 May 27.

17.

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.

Santiago AE, Mann BJ, Qin A, Cunningham AL, Cole LE, Grassel C, Vogel SN, Levine MM, Barry EM.

Pathog Dis. 2015 Aug;73(6):ftv036. doi: 10.1093/femspd/ftv036. Epub 2015 May 17.

18.

Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.

Mandapati K, Gorla SK, House AL, McKenney ES, Zhang M, Rao SN, Gollapalli DR, Mann BJ, Goldberg JB, Cuny GD, Glomski IJ, Hedstrom L.

ACS Med Chem Lett. 2014 Jun 10;5(8):846-50. doi: 10.1021/ml500203p. eCollection 2014 Aug 14. Erratum in: ACS Med Chem Lett. 2014 Oct 9;5(10):1174.

19.

FipB, an essential virulence factor of Francisella tularensis subsp. tularensis, has dual roles in disulfide bond formation.

Qin A, Zhang Y, Clark ME, Rabideau MM, Millan Barea LR, Mann BJ.

J Bacteriol. 2014 Oct;196(20):3571-81. doi: 10.1128/JB.01359-13. Epub 2014 Aug 4.

20.

Risk-Prone Pitching Activities and Injuries in Youth Baseball: Findings From a National Sample.

Yang J, Mann BJ, Guettler JH, Dugas JR, Irrgang JJ, Fleisig GS, Albright JP.

Am J Sports Med. 2014 Jun;42(6):1456-63. doi: 10.1177/0363546514524699. Epub 2014 Mar 13.

PMID:
24627578
21.

Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.

Reed DS, Smith LP, Cole KS, Santiago AE, Mann BJ, Barry EM.

Infect Immun. 2014 May;82(5):2098-105. doi: 10.1128/IAI.01498-14. Epub 2014 Mar 10.

22.

Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Richard K, Mann BJ, Stocker L, Barry EM, Qin A, Cole LE, Hurley MT, Ernst RK, Michalek SM, Stein DC, Deshong P, Vogel SN.

Clin Vaccine Immunol. 2014 Feb;21(2):212-26. doi: 10.1128/CVI.00738-13. Epub 2013 Dec 18.

23.

Eg5 restricts anaphase B spindle elongation in mammalian cells.

Collins E, Mann BJ, Wadsworth P.

Cytoskeleton (Hoboken). 2014 Feb;71(2):136-44. doi: 10.1002/cm.21158. Epub 2013 Dec 12.

24.

Adherence and uptake of Francisella into host cells.

Moreau GB, Mann BJ.

Virulence. 2013 Nov 15;4(8):826-32. doi: 10.4161/viru.25629. Epub 2013 Jul 10. Review.

25.

Structure-Function Analysis of DipA, a Francisella tularensis Virulence Factor Required for Intracellular Replication.

Chong A, Child R, Wehrly TD, Rockx-Brouwer D, Qin A, Mann BJ, Celli J.

PLoS One. 2013 Jun 26;8(6):e67965. doi: 10.1371/journal.pone.0067965. Print 2013.

26.

Quantifying clinically significant change: a brief review of methods and presentation of a hybrid approach.

Mann BJ, Gosens T, Lyman S.

Am J Sports Med. 2012 Oct;40(10):2385-93. Epub 2012 Sep 7.

PMID:
22962295
27.

Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis.

Qin A, Scott DW, Rabideau MM, Moore EA, Mann BJ.

PLoS One. 2011;6(9):e24611. doi: 10.1371/journal.pone.0024611. Epub 2011 Sep 8.

28.

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y, Gearhart PJ, Chesko KL, Viscardi RM, Vogel SN.

J Leukoc Biol. 2011 Oct;90(4):787-97. doi: 10.1189/jlb.0111014. Epub 2011 Jul 12.

29.

Impact of Francisella tularensis pilin homologs on pilus formation and virulence.

Ark NM, Mann BJ.

Microb Pathog. 2011 Sep;51(3):110-20. doi: 10.1016/j.micpath.2011.05.001. Epub 2011 May 13.

30.

Descriptive epidemiology of the Multicenter ACL Revision Study (MARS) cohort.

MARS Group, Wright RW, Huston LJ, Spindler KP, Dunn WR, Haas AK, Allen CR, Cooper DE, DeBerardino TM, Lantz BB, Mann BJ, Stuart MJ.

Am J Sports Med. 2010 Oct;38(10):1979-86. doi: 10.1177/0363546510378645.

31.

Regulation of Virulence of Entamoeba histolytica by the URE3-BP Transcription Factor.

Gilchrist CA, Moore ES, Zhang Y, Bousquet CB, Lannigan JA, Mann BJ, Petri WA.

MBio. 2010 May 18;1(1). pii: e00057-10. doi: 10.1128/mBio.00057-10.

32.

Azithromycin effectiveness against intracellular infections of Francisella.

Ahmad S, Hunter L, Qin A, Mann BJ, van Hoek ML.

BMC Microbiol. 2010 Apr 23;10:123. doi: 10.1186/1471-2180-10-123.

33.
34.

Rationally designed tularemia vaccines.

Mann BJ, Ark NM.

Expert Rev Vaccines. 2009 Jul;8(7):877-85. doi: 10.1586/erv.09.51. Review.

35.

Identification of an essential Francisella tularensis subsp. tularensis virulence factor.

Qin A, Scott DW, Thompson JA, Mann BJ.

Infect Immun. 2009 Jan;77(1):152-61. doi: 10.1128/IAI.01113-08. Epub 2008 Nov 3.

36.

Targets of the Entamoeba histolytica transcription factor URE3-BP.

Gilchrist CA, Baba DJ, Zhang Y, Crasta O, Evans C, Caler E, Sobral BW, Bousquet CB, Leo M, Hochreiter A, Connell SK, Mann BJ, Petri WA.

PLoS Negl Trop Dis. 2008;2(8):e282. doi: 10.1371/journal.pntd.0000282. Epub 2008 Aug 27.

37.

Development of the Gateway system for cloning and expressing genes in Entamoeba histolytica.

Abhyankar MM, Hochreiter AE, Connell SK, Gilchrist CA, Mann BJ, Petri WA Jr.

Parasitol Int. 2009 Mar;58(1):95-7. doi: 10.1016/j.parint.2008.08.004. Epub 2008 Sep 12.

38.

Characterization of an Entamoeba histolytica high-mobility-group box protein induced during intestinal infection.

Abhyankar MM, Hochreiter AE, Hershey J, Evans C, Zhang Y, Crasta O, Sobral BW, Mann BJ, Petri WA Jr, Gilchrist CA.

Eukaryot Cell. 2008 Sep;7(9):1565-72. doi: 10.1128/EC.00123-08. Epub 2008 Jul 25.

39.

Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.

Qin A, Scott DW, Mann BJ.

Infect Immun. 2008 Jul;76(7):3086-92. doi: 10.1128/IAI.00363-08. Epub 2008 May 5.

40.

Structure and content of the Entamoeba histolytica genome.

Clark CG, Alsmark UC, Tazreiter M, Saito-Nakano Y, Ali V, Marion S, Weber C, Mukherjee C, Bruchhaus I, Tannich E, Leippe M, Sicheritz-Ponten T, Foster PG, Samuelson J, Noël CJ, Hirt RP, Embley TM, Gilchrist CA, Mann BJ, Singh U, Ackers JP, Bhattacharya S, Bhattacharya A, Lohia A, Guillén N, Duchêne M, Nozaki T, Hall N.

Adv Parasitol. 2007;65:51-190.

PMID:
18063096
41.

Allograft update: the current status of tissue regulation, procurement, processing, and sterilization.

McAllister DR, Joyce MJ, Mann BJ, Vangsness CT Jr.

Am J Sports Med. 2007 Dec;35(12):2148-58. Epub 2007 Nov 1.

PMID:
17974862
42.

A survey of sports medicine physicians regarding psychological issues in patient-athletes.

Mann BJ, Grana WA, Indelicato PA, O'Neill DF, George SZ.

Am J Sports Med. 2007 Dec;35(12):2140-7. Epub 2007 Jul 19.

PMID:
17641103
43.

Therapeutic alliance and treatment progress in couple psychotherapy.

Knobloch-Fedders LM, Pinsof WM, Mann BJ.

J Marital Fam Ther. 2007 Apr;33(2):245-57.

PMID:
17437462
44.

Understanding and preventing noncontact anterior cruciate ligament injuries: a review of the Hunt Valley II meeting, January 2005.

Griffin LY, Albohm MJ, Arendt EA, Bahr R, Beynnon BD, Demaio M, Dick RW, Engebretsen L, Garrett WE Jr, Hannafin JA, Hewett TE, Huston LJ, Ireland ML, Johnson RJ, Lephart S, Mandelbaum BR, Mann BJ, Marks PH, Marshall SW, Myklebust G, Noyes FR, Powers C, Shields C Jr, Shultz SJ, Silvers H, Slauterbeck J, Taylor DC, Teitz CC, Wojtys EM, Yu B.

Am J Sports Med. 2006 Sep;34(9):1512-32.

PMID:
16905673
46.

Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome.

Gilchrist CA, Houpt E, Trapaidze N, Fei Z, Crasta O, Asgharpour A, Evans C, Martino-Catt S, Baba DJ, Stroup S, Hamano S, Ehrenkaufer G, Okada M, Singh U, Nozaki T, Mann BJ, Petri WA Jr.

Mol Biochem Parasitol. 2006 Jun;147(2):163-76. Epub 2006 Mar 7.

PMID:
16569449
47.

Kinetics and strain variation of phagosome proteins of Entamoeba histolytica by proteomic analysis.

Okada M, Huston CD, Oue M, Mann BJ, Petri WA Jr, Kita K, Nozaki T.

Mol Biochem Parasitol. 2006 Feb;145(2):171-83. Epub 2005 Oct 19.

PMID:
16290089
48.

The International Knee Documentation Committee Subjective Knee Evaluation Form: normative data.

Anderson AF, Irrgang JJ, Kocher MS, Mann BJ, Harrast JJ; International Knee Documentation Committee.

Am J Sports Med. 2006 Jan;34(1):128-35. Epub 2005 Oct 11.

PMID:
16219941
49.

Proteomic analysis of Gal/GalNAc lectin-associated proteins in Entamoeba histolytica.

McCoy JJ, Mann BJ.

Exp Parasitol. 2005 Jul;110(3):220-5. Epub 2005 Mar 17.

PMID:
15955316
50.

Proteomic analysis of phagocytosis in the enteric protozoan parasite Entamoeba histolytica.

Okada M, Huston CD, Mann BJ, Petri WA Jr, Kita K, Nozaki T.

Eukaryot Cell. 2005 Apr;4(4):827-31.

Supplemental Content

Support Center